Meeting
2023 ASCO Genitourinary Cancers Symposium
Cost savings associated with palliative care among patients with genitourinary malignancies.
Authors
Phichai Chansriwong
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Phichai Chansriwong , Nintita Sripaibookij Thokanit , Siriporn Semsarn , Pinyo Utthiya , Vijj Kasemsup
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 474)
DOI
10.1200/JCO.2023.41.6_suppl.474
Abstract #
474
Poster Bd #
H15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Regulatory approvals for genitourinary (GU) cancer by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) over 20 years (2003-2023).
First Author: Sanjay Khanna
Poster
2023 ASCO Quality Care Symposium
The PaCES Study: Cost effectiveness of an early palliative care intervention in patients with advanced colorectal cancer.
First Author: Aynharan Sinnarajah
Poster
2022 ASCO Annual Meeting
Systematic performance status assessment by primary care providers in patients with advanced cancer and its impact on referral to palliative care and cost in a value-based practice.
First Author: Roberto Enrique Ochoa
Poster
2022 ASCO Genitourinary Cancers Symposium
Distribution of immune-related adverse events (irAEs) across genitourinary (GU) malignancies.
First Author: Nataliya Mar